ArticleMolecular medicine reports2019

SM‑164 enhances the antitumor activity of adriamycin in human U2‑OS cells via downregulation of X‑linked inhibitor of apoptosis protein.

Jiangwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.